quantitative
Analysis v1
Strong Support
For adults who are overweight, have heart disease, but don’t have diabetes, taking a weekly semaglutide shot might help slow down how fast their kidneys lose function each year.
73
0
Evidence from Studies
Supporting (1)
73
Community contributions welcome
73
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Randomized Controlled Trial
Human
2024 JulThe study tested the same drug, dose, and patient group as the claim and found that semaglutide helped protect kidney function, which supports the idea that it slows kidney decline.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.